cascade blue has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacigaluppi, M; Doeppner, TR; ElAli, A; Guo, Z; Hagen, SI; Hermann, DM; Herz, J; Kilic, E; Kilic, U; Pluchino, S; Reinboth, BS; Reitmeir, R; Zechariah, A | 1 |
1 other study(ies) available for cascade blue and Disease Models, Animal
| Article | Year |
|---|---|
Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions.
Topics: Animals; Anti-Inflammatory Agents; Biotin; Brain Edema; Cerebral Cortex; Cerebral Infarction; Cytokines; Dextrans; Disease Models, Animal; Functional Laterality; Gene Expression Regulation; Hand Strength; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Degeneration; Neural Pathways; Neuronal Plasticity; Organometallic Compounds; Organophosphorus Compounds; Red Nucleus; Vascular Endothelial Growth Factor A | 2012 |